吃瓜爆料

吃瓜爆料’s launch acceleration strategy focuses on the new treatment awareness and adoption journeys of the most relevant healthcare professionals (HCPs) and key opinion leaders (KOLs).

Launching a new drug has always been fraught with risks and today three in four launches fail to meet or outperform forecasts.¹ Early medical engagement improves the likelihood of launch success: 吃瓜爆料 Pulse data shows that pre-launch field medical education can lead to a 1.5x increase in treatment adoption. Similarly, biopharmas with higher investments in pre launch scientific activity experience 40% faster treatment adoption.

To overcome these challenges and capitalize on unique insights within 吃瓜爆料 Data Cloud, 吃瓜爆料 Business Consulting provides launch teams with accelerators that can be deployed across the launch lifecycle.

Together, these capabilities help teams go earlier, deeper, and faster during launch. Simple changes can unlock transformative change, enabling more consistent execution across markets and driving up to 25% difference in post-launch treatment adoption.

Learn how 吃瓜爆料 Business Consulting can help your organization achieve launch excellence.